5 Things You Need to Know About COVID, Flu and RSV Vaccines This Fall
Sanofi on Pace for Highest Close Since April 2023 -- Data Talk
Inhibrx Gains After Insider Purchases From CEO
Biopharmaceuticals Global Business Report 2024 With Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli Lilly and Co, F. Hoffmann-La Roche, J&J, Merck, Novo Nordisk, Pfizer, Sanofi
PAI Said to Rope in Sovereign Funds for Sanofi Consumer Unit Bid
FTC Says FDA Biosimilar Guidance Would Increase Competition, Lead to Lower Prices
ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 Years:' Analyst
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Progyny (PGNY) and Health Catalyst (HCAT)
J&J, Roche Come Out on Top in S&P Ratings of Strongest Pharma Companies
Unusual Options Activity: SNY, MSTR and Others Attract Market Bets, SNY V/OI Ratio Reaches 136.4
Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
Sanofi Hits 42-week High
The Zacks Analyst Blog Highlights Meta Platforms, Sanofi, CME and The Cato
Top Stock Reports for Meta, Sanofi & CME
Anaptys Offering Led by Longstanding Investor EcoR1 Capital, With Participation From Existing and New Investors Including Sanofi >ANAB
Express News | Vigil Neuroscience Q2 2024 GAAP EPS $(0.52) Beats $(0.55) Estimate, The Company Expects Its Cash, Cash Equivalents And Marketable Securities Of $86.7M, Together With The $40M Gross Proceeds Received From Sanofi In July, Will Fund Its Operational Plans...
Express News | Vigil Neuroscience Inc: Announced $40 Mln Strategic Investment From Sanofi; Extended Cash Runway Into 2026
Sanofi's Sarclisa Enhances Multiple Myeloma Survival
MeiraGTx Offering of 12.5M Shrs Prices at $4/Shr >MGTX
Express News | MeiraGTx Holdings: Financing Led by Sanofi, Which Made a $30 Mln Equity Investment in Co Through Offering